Mesenchymal Stem Cells From Mouse Hair Follicles Reduce Hypertrophic Scarring in a Murine Wound Healing Model
Authors:
- Hanluo LiHLHanluo Li
- Mirjana ZiemerMZMirjana Ziemer
- Ivana StojanovicISIvana Stojanovic
- Tamara SaksidaTSTamara Saksida
- Danijela Maksimovic-IvanicDMDanijela Maksimovic-Ivanic
- Sanja MijatovicSMSanja Mijatovic
- Goran DjmuraGDGoran Djmura
- Dragica GajicDGDragica Gajic
- Tamara KrajnovicTKTamara Krajnovic
- Jan-Christoph SimonJSJan-Christoph Simon
Open Access
- 26 January 2022
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 18 (6) , 2028-2044
Abstract
Wound healing of acute full-thickness injuries and chronic non-healing ulcers leads to delayed wound closure, prolonged recovery period and hypertrophic scarring, generating a demand for an autologous cell therapy and a relevant pre-clinical research models for wound healing. In this study, an immunocompetent model for wound healing was employed using a syngeneic murine cell line of mesenchymal stem cells cultured from the mouse whisker hair follicle outer root sheath (named moMSCORS). moMSCORS were isolated using an air-liquid interface method, expanded in vitro and characterized according to the MSC definition criteria - cell viability, in vitro proliferation, MSC phenotype and multi-lineage differentiations. Moreover, upon applying moMSCORS in an in vivo full-thickness wound model in the syngeneic C57BL/6 mice, the treated wounds displayed different morphology to that of the untreated wound beds. Quantitative evaluation of angiogenesis, granulation and wound closure involving clinical scoring and software-based quantification indicated a lower degree of inflammation in the treated wounds. Histological staining of treated wounds by the means of H&E, Alcian Blue, PicroSirius Red and αSMA immune labelling showed lower cellularity, less collagen filaments as well as thinner dermal and epidermal layers compared with the untreated wounds, indicating a general reduction of hypertrophic scars. The decreased inflammation, accelerated wound closure and non-hypertrophic scarring, which were facilitated by moMSCORS, hereby address a common problem of hypertrophic scars and non-physiological tissue properties upon wound closure, and additionally offer an in vivo model for the autologous cell-based wound healing. Graphic AbstractKeywords
Funding Information
- Sächsisches Staatsministerium für Wissenschaft und Kunst (Sächsisches Staatsministerium für Wissenschaft und Kunst)
- Deutsche Forschungsgemeinschaft (TRR 67 B12 to VS and B3 to SF and JCS)
- Erasmus+ (D LEIPZIG 01, 01-1189)
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (#451-03-9/2021-14/200007, 6370516)
- Universität Leipzig
This publication has 47 references indexed in Scilit:
- The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a ParadigmMolecular Therapy, 2013
- Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-αNature Protocols, 2012
- Concise Review: Role of Mesenchymal Stem Cells in Wound RepairStem Cells Translational Medicine, 2012
- SnapShot: Hair Follicle Stem CellsCell, 2011
- Surgical Approaches to Create Murine Models of Human Wound HealingBioMed Research International, 2010
- Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrowJournal of Experimental Medicine, 2009
- Promotion of incisional wound repair by human mesenchymal stem cell transplantationExperimental Dermatology, 2009
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Pluripotent neural crest stem cells in the adult hair follicleDevelopmental Dynamics, 2004